Regeneron Pharmaceuticals reported $81.19B in Market Capitalization this November of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Agenus AGEN:US USD 581M 57M
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Alimera Sciences ALIM:US USD 36M 2M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Amgen AMGN:US USD 120.36B 9.61B
Astellas Pharma 4503:JP JPY 3.52T 363.5B
AstraZeneca AZN:LN USD 154.08B 13.26B
Biogen BIIB:US USD 39.1B 9.24B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Bluebird Bio BLUE:US USD 488M 192M
Bristol Myers Squibb BMY:US USD 151.8B 12.14B
Eli Lilly And LLY:US USD 307.24B 831M
Esperion Therapeutics ESPR:US USD 446M 45M
Gilead Sciences GILD:US USD 77.36B 170M
GlaxoSmithKline GSK:LN GBP 53.11B 36.65B
Intercept Pharmaceuticals ICPT:US USD 574M 164M
IONIS PHARMACEUT IONS:US USD 6.28B 1.03B
Johnson & Johnson JNJ:US USD 429.5B 37.6B
Kyowa Hakko Kirin 4151:JP JPY 1.79T 143.1B
Merk MRK:US USD 218.17B 12.39B
Moderna Inc MRNA:US USD 46.26B 10.56B
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Novartis NVS:US USD 183.98B 19.54B
Novartis NOVN:VX USD 181.55B 12.79B
Ophthotech OPHT:US USD 2.12B 998M
Opthea Ltd OPT:AU USD 387.37M 68.39M
Pfizer PFE:US USD 245.6B 48.58B
Puma Biotechnology PBYI:US USD 108M 20M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 268.62B 31.88B
Sanofi SNY:US EUR 97.37B 30.4B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Seattle Genetics SGEN:US USD 25.24B 7.33B
Teva Pharmaceutical TEVA:IT USD 30.77B 1.12B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
United Therapeutics UTHR:US USD 9.53B 1.14B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
YTE INCY:US USD 14.82B 2.01B